Yi Larson - Jun 17, 2022 Form 4/A - Amendment Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: Director
Signature: /s/ John B. Moriarty, Jr., Attorney-in-Fact
Stock symbol: OLMA
Transactions as of: Jun 17, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 6/27/2022, 05:16 PM
Date Of Original Report: Jun 17, 2022
Previous filing: Jun 17, 2022
Next filing: Jan 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Award	$0	+21.5K		$0.00	21.5K	Jun 17, 2022	Common Stock	21.5K	$3.61	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment is being filed solely for the purpose of correcting the transaction date and exercise price. The correct transaction date is "June 17, 2022" and the correct exercise price is "$3.61" as shown herein.
F2	The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 17, 2022, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.

Content

This amendment is being filed solely for the purpose of correcting the transaction date and exercise price. The correct transaction date is "June 17, 2022" and the correct exercise price is "$3.61" as shown herein.

The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 17, 2022, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.